Article
The SP1 sites of the human apoCIII enhancer are essential for the expression of the apoCIII gene and contribute to the hepatic and intestinal expression of the apoA-I gene in transgenic mice.
Nucleic acids research - 15 Dec 2000
Georgopoulos S, Kan H Y, Reardon-Alulis C, Zannis V
Abstract excerpt
We have generated transgenic mice carrying wild-type and mutant forms of the apolipoprotein (apo)A-I/apoCIII gene cluster. Mutations were introduced either in one or in three SP1 binding sites of the apoCIII enhancer. In mice carrying the wild-type transgene, major sites of apoA-I mRNA synthesis were liver and intestine and minor sites were kidney and, to a lesser extent, other tissues. The major site of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
